Compare XRX & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRX | CBUS |
|---|---|---|
| Founded | 1906 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.6M | 121.1M |
| IPO Year | 2019 | 2017 |
| Metric | XRX | CBUS |
|---|---|---|
| Price | $2.67 | $1.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 5.1M | 617.1K |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 6.31% | N/A |
| EPS Growth | 23.26 | ★ 74.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $117,000,000.00 | $3,639,000.00 |
| Revenue This Year | $8.96 | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.19 | $1.09 |
| 52 Week High | $6.80 | $4.19 |
| Indicator | XRX | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 80.23 | 39.95 |
| Support Level | $2.40 | $1.43 |
| Resistance Level | $2.89 | $1.50 |
| Average True Range (ATR) | 0.19 | 0.11 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 97.59 | 52.94 |
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.